The Role of School-Based Health Centres in Advancing Health Equity

By Melike Belenli Gümüş

October 3, 2024

Introduction

School-based health centres (SBHCs) are crucial in providing healthcare services to underserved youth in the United States. These centres provide essential healthcare services directly within schools, ensuring that students have easy access to medical care. Located in elementary, middle, and high schools, SBHCs primarily serve low-income communities, offering primary care, reproductive health, mental health, dental, vision, and nutrition services. These centres are staffed by a multidisciplinary team, including physicians, nurse practitioners, mental health providers. SBHCs improve both health and educational outcomes by increasing access to care and partnering with schools and paediatric healthcare providers. They play an important role in both advancing health equity and enhancing educational outcomes.

Background and Current State

The origins of SBHCs date back to the 1960s and 1970s. These early centres aimed to enhance care for underserved students and improve prenatal care for teen mothers. As of the 2016-2017 Census by the School-Based Health Alliance (SBHA), there are 2,584 SBHCs across 48 states, Puerto Rico, and the District of Columbia. These centres serve over 6 million students in various communities. Most SBHCs are located on school campuses, while others are mobile or telehealth-exclusive. Federally qualified health centres sponsor 51% of SBHCs, and all provide primary care services.

SBHCs and Access to Care

SBHCs are instrumental in bridging gaps in care for underserved youth, particularly those who are uninsured or underinsured. These centres offer comprehensive medical services, including preventive care, management of chronic conditions, and reproductive health services. By providing care on-site, SBHCs reduce the need for travel and ensure that students miss less school. Confidentiality is maintained, allowing adolescents to seek care without parental involvement.

Management of Chronic Health Conditions

SBHCs play a crucial role in managing chronic health conditions like asthma and obesity. Asthma is the most common chronic illness in children. SBHCs can initiate treatment, provide urgent care, and promote medication adherence. Studies have shown that SBHCs reduce asthma-related hospitalisations and improve school attendance.

Childhood obesity is another significant concern, particularly those from low-income households. SBHCs screen for obesity and related conditions and offer educational interventions. A study in New Mexico found that a SBHC weight management program led to improvements in body mass index (BMI) and waist circumference.

The Role of SBHCs in Advancing Health Equity

A Community Guide systematic review in 2016 highlighted the effectiveness of SBHCs in improving educational and health-related outcomes. According to this review, SBHCs were associated with higher grade point average (GPA), grade promotion, and reduced school suspensions. Health outcomes improved as well, with increased immunisation rates, reduced asthma-related hospitalisations, and better reproductive health indicators.

Educational Outcomes

SBHCs positively impact educational outcomes by reducing absenteeism and improving academic performance. Studies have shown that SBHC users have higher GPAs and are more likely to be promoted to the next grade. One study found that SBHC use was associated with a 33% reduction in school dropout rates, particularly among high-risk students. SBHCs also support pregnant adolescents, helping them stay in school and achieve better educational outcomes.

Cost Effectiveness of SBHCs

SBHCs are not only beneficial for students but also cost-effective, reducing healthcare and societal costs. They decrease emergency department visits, hospitalisations, and missed time from work and school, providing a high return on investment. Wade and Guo demonstrated that SBHCs reduce Medicaid costs by improving students’ health-related quality of life (HRQoL). Moreover, a systematic review found that the societal benefit of SBHCs ranged from $15,028 to $912,878 annually. Another study in Ohio reported a net social benefit of $1.35 million over three years of SBHC operation.

Conclusion

SBHCs are important healthcare facilities that promote health equity among youth and improve their educational outcomes. They reduce health disparities, offer cost-effective care, and support the academic success of students. However, there are several challenges that SBHCs face. Many SBHCs rely on grants and external funding, which can be unpredictable. Moreover, there is a need for better integration with primary care providers to ensure continuity of care. Future efforts should focus on securing stable funding sources and enhancing collaboration between SBHCs and other healthcare providers.

Reference url

Recent Posts

suzetrigine pain management
      

Journavx for Pain Management: Toward Affordability and Access

💊 The jury is out on the pricing for Journavx®

Delve into our review of the recent ICER 2025 report on suzetrigine (Journavx®) to learn about the anticipated value relative to its clinical efficacy, safety profile and potential cost savings in tackling acute pain while addressing the opioid crisis.

Explore how suzetrigine paves the way for a safer, more effective approach to pain management and its implications on healthcare economics.

#SyenzaNews #HealthEconomics #HealthcareInnovation #Journavx

defunding scientific research
      

Defunding Scientific Research: Implications and Misconceptions in Gawande’s Analysis of Harvard Funding Cuts

🚨 What happens when scientific research funding is threatened?

In his thought-provoking article, Atul Gawande highlights the dire implications of proposed federal funding cuts to elite institutions like Harvard. He argues that such actions could devastate not just innovation, but also patient care and public health across the nation.

Explore the complexities of research funding and the potential ripple effects on America’s scientific landscape. Don’t miss out on these critical insights!

#SyenzaNews #HealthcareInnovation #HealthEconomics #MarketAccess

perioperative immunotherapy bladder cancer
       

FDA Approves Perioperative Immunotherapy for Bladder Cancer: A Breakthrough in MIBC Treatment

🚀 Are we witnessing a new era in bladder cancer treatment?

The FDA’s recent approval of durvalumab as the first perioperative immunotherapy for muscle-invasive bladder cancer (MIBC) could revolutionize outcomes for patients facing this formidable diagnosis. With significant improvements in event-free survival and overall survival over standard chemotherapy, this groundbreaking treatment offers new hope 🎉.

Curious about how this could shape the future of cancer care? Dive into the full article to uncover the potential impacts on clinical practice and health economics.

#SyenzaNews #oncology #HealthEconomics

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.